Does IRBESARTAN Cause Heart failure with preserved ejection fraction? 48 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Heart failure with preserved ejection fraction have been filed in association with IRBESARTAN (Irbesartan). This represents 0.5% of all adverse event reports for IRBESARTAN.
48
Reports of Heart failure with preserved ejection fraction with IRBESARTAN
0.5%
of all IRBESARTAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Heart failure with preserved ejection fraction From IRBESARTAN?
Of the 48 reports.
Is Heart failure with preserved ejection fraction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Heart failure with preserved ejection fraction?
RITUXIMAB (66)
CYCLOPHOSPHAMIDE (60)
FUROSEMIDE (58)
HYDROXYCHLOROQUINE (55)
ALLOPURINOL (54)
PANTOPRAZOLE (54)
AZATHIOPRINE (48)
CALCIUM (48)
COLCHICINE (48)
DARBEPOETIN ALFA (48)
Which IRBESARTAN Alternatives Have Lower Heart failure with preserved ejection fraction Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE